The effects of octreotide in a patient with Nelson's syndrome

Creative Commons License

Kelestimur F., Utaş C., Ozbakir O., Selcuklu A., Kandemir O., Ozcan N.

POSTGRADUATE MEDICAL JOURNAL, cilt.72, sa.843, ss.53-54, 1996 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 72 Sayı: 843
  • Basım Tarihi: 1996
  • Doi Numarası: 10.1136/pgmj.72.843.53
  • Dergi Adı: POSTGRADUATE MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.53-54
  • Erciyes Üniversitesi Adresli: Evet

Özet

We have administered octreotide, 100 mu g tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.